Gosuranemab

DB15376Investigational

Gosuranemab is under investigation in clinical trial NCT02460094 (Multiple Ascending Dose Study of Intravenously Administered BMS-986168 (BIIB092) in Patients With Progressive Supranuclear Palsy).

Mechanism: Pharmacologically active on Microtubule-associated protein tau
Curator reviewed
Also known as: BMS-986168
Code names: BIIB092

Resolves to

Compound

UNII09FZ7Q0PQZCAS1788032-39-2

Targets

P10636MAPT

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

6Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Gosuranemab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account